Insider: SCHIFF ANDREW N Director - Aclaris Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 0 | 434,455 | 434,455 |
| Value | $0.00 | $864,565.45 | $864,565.45 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/14/2022 | DDS | 1,371 | Indirect | COM | $17.08 | $23,416.68 | 434,455 |
| 11/11/2022 | DDS | 41,160 | Indirect | COM | $17.06 | $702,177.25 | 435,826 |
| 11/10/2022 | DDS | 11,395 | Indirect | COM | $17.02 | $193,995.32 | 476,986 |
| 10/26/2022 | DDS | 14,540 | Indirect | COM | $17.01 | $247,252.70 | 488,381 |
| 10/25/2022 | DDS | 12,018 | Indirect | COM | $17.02 | $204,516.32 | 502,921 |
| 10/24/2022 | DDS | 14,616 | Indirect | COM | $17.01 | $248,586.00 | 514,939 |
| 10/18/2022 | DDS | 32,093 | Indirect | COM | $16.89 | $542,021.89 | 529,555 |
| 10/17/2022 | DDS | 19,944 | Indirect | COM | $16.05 | $320,087.24 | 561,648 |
| 10/07/2022 | DDS | 7,324 | Indirect | COM | $16.16 | $118,349.25 | 581,592 |
| 10/06/2022 | DDS | 37,839 | Indirect | COM | $16.54 | $625,743.54 | 588,916 |
| 10/04/2022 | DDS | 7,700 | Indirect | COM | $16.01 | $123,258.52 | 626,755 |
| 06/17/2022 | DDS | 19,565 | Direct | COM | $15.14 | $296,268.88 | 0 |
| 08/16/2017 | AAP | 108,601 | Indirect | COM | $23.02 | $2,499,995.02 | 634,455 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research